Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

of Health (NIH). This compares to $893,002 of grant revenue reported for the same period in 2011. As of March 31, 2012, there is approximately $3.3 million in unused IPCAVD grant funds available for use through August 31, 2012 (the end of the original project period).

Research and development (R&D) expenses were $1,072,354 for the three months ended March 31, 2012, compared with $838,467 for the comparable period in 2011. R&D expenses include direct costs funded by the IPCAVD grant, as well as vaccine manufacturing costs and expenses related to the Phase 1/2 clinical trial, being sponsored by GeoVax, of the Company's therapeutic HIV vaccine. Costs associated with the Phase 2a clinical trial of GeoVax's preventative HIV vaccine, being conducted by the HVTN, are being funded directly by the NIH and are therefore not reflected in GeoVax's financial statements. General and administrative (G&A) expenses were $512,818 and $661,813 for the three months ended March 31, 2012 and 2011, respectively.

GeoVax reported cash balances of $2,240,486 at March 31, 2012, as compared to $1,167,980 at December 31, 2011. Summarized financial information is attached. Further information concerning the Company's financial position and results of operations are included in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.

About GeoVax's TechnologyGeoVax's unique two component vaccine, a recombinant DNA and a recombinant modified vaccinia Ankara (MVA), is designed to stimulate both anti-HIV T cell and anti-HIV antibody immune responses. GeoVax's DNA and MVA vaccines are used in a prime/boost protocol in which priming is done with the DNA and boosting with the MVA. Both the DNA and MVA express the three major proteins of the AIDS virus: Gag, Pol, and Env, and produce non-infectious virus-like-particles. GeoVax's vaccines are unique in expressing virus-like particles that display the trimeric membrane bound form of the HIV-
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015  Cannabis Science, Inc. ... of cannabis-based medicine, today announced two important developments: It ... multiple global product launches, and CEO Raymond C. ... Chicago HR Examiner. In the article, Dabney ... about leading a company in an industry that is ...
(Date:3/3/2015)... 2015  Tru-D SmartUVC will exhibit the cutting-edge ... Registered Nurses, Surgical Conference and Expo 2015 in ... Safety Awareness Week March 7 through 11. AORN ... practice and professional development. Photo ... http://photos.prnewswire.com/prnh/20150302/178998LOGO   Tru-D SmartUVC,s UV ...
(Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/tvmk72/the_generic_drugs ... new report "The Generic Drugs Market: 2015 ... to their offering. , ... intended to be interchangeable with an innovator product, ... innovator company and marketed after the expiry date ...
Breaking Medicine Technology:CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 3CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 4CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 5Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 2Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 3Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 2Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 3Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 4Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 5Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts' 6
... CARSON CITY, Nev., April 11, 2011 Rapid ... announced today that their wholly owned subsidiary, Medical ... legal channels to begin cultivation and growing of medical ... of the Company,s business will significantly increase revenue and ...
... GREENVILLE, S.C., April 11, 2011 KEMET Corporation ... of tantalum, ceramic, aluminum, film, paper and electrolytic ... (TSM) Series capacitors. The TSM Series is targeted ... space in the computer, consumer/gaming, medical, military/aerospace, telecommunications ...
Cached Medicine Technology:Rapid Fire Marketing: Medical Cannabis Management Cleared for Medical Cannabis Cultivation 2KEMET Introduces Tantalum Stacked Capacitors 2KEMET Introduces Tantalum Stacked Capacitors 3
(Date:3/3/2015)... 2015 Claflin Medical Equipment, ... Veterans Affairs has signed a new, five year contract ... , Under the contract, the company will provide ... U.S. Military, Indian Health Services, National Institute of Health, ... with competitive pricing for hospital equipment and related services. ...
(Date:3/3/2015)... Miami, FL (PRWEB) March 03, 2015 ... reversal of type I diabetes, type II diabetes, and ... in 30 Days offers a way for diabetes sufferers ... treatments or pharmaceutical drugs. , In 2013, the ... diabetes sufferers. These pharmaceutical treatments often include the use ...
(Date:3/3/2015)... March 03, 2015 T-System Inc. ... BSN, MBA, CEN, CPHQ, FABC as the company’s chief ... innovation for unscheduled, episodic care. , “Today’s ... episodic care settings including urgent care and freestanding emergency ... healthcare,” said Roger Davis, T-System’s chief executive officer. ...
(Date:3/3/2015)... March 03, 2015 The Data 360 ... at the Ford Conference Center, Dearborn, MI, on March 5, ... Inc., is a featured speaker. He is known internationally as ... , These designations were earned due to years of ... commercially-available NoSQL DB, released over 10 years ago. Subsequent developments ...
(Date:3/3/2015)... The authors Tracey Webb and Richard Mowbray ... future is a good and healthy diet . In ... have a created an ingenious book that shows readers how ... vegan meals. , “Crude Food” shows readers that, in modern ... caused by over processed refined foods , such as ...
Breaking Medicine News(10 mins):Health News:Claflin Medical Equipment (CME) Announces New 5 Year Contract with the Department of Veterans Affairs (VA) 2Health News:New Breakthrough In Diabetes Reaserch Show Scientifically Proven Way To Reverse Your Diabetes Naturally In 30 Short Days 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 2Health News:New book ‘Crude Food’ gives readers ingenious ways to create healthy meals 3
... 15 to 21 Percent, FRANKLIN LAKES, N.J., Nov. 5 , ... to a record $0.58 from $0.39 in ... intangible assets from the 2003 spin-off, increased ... third-quarter 2007 -- Both GAAP diluted EPS, and diluted EPS ...
... N.J., Nov. 5 BD (Becton,Dickinson and Company) (NYSE: ... Forlenza as President, effective January 1, 2009, and David ... effective,December 1, 2008., Mr. Forlenza will report to ... Executive Officer. Mr. Elkins will also report to Mr.,Ludwig. ...
... LAKES, N.J., Nov. 5 BD (Becton,Dickinson and Company) ... billion for the fourth fiscal quarter ended September 30, ... year period. This,quarter,s growth rate reflects the favorable impact ... estimated to account for 5,percentage points of the increase ...
... Nov. 5 Californians for SAFE Food, the,statewide ... extends sincere,gratitude to the California family farmers, food ... labor and community,groups who lent their energy, expertise ... The Yes on 2 campaign, backed by ...
... asset impairment charge, - Improvements beginning to be ... The Providence Service,Corporation (Nasdaq: PRSC ) today ... 30, 2008. Included in the results is an estimated ... charge related,to the Company,s goodwill and certain of its ...
... a new report from Harvard Medical School. The report, Viruses and Infectious ... and urges adults to seek out new vaccines and renew their old ... ... are not up to date on their vaccinations, says a new report ...
Cached Medicine News:Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 2Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 3Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 4Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 5Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 6Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 7Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 8Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 9Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 10Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 11Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 12Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 13Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 14Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 15Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 16Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 17Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 18Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 19Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 20Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 21Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 22Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 23Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 24Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 25Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 26Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 27Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 28Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 29Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 30Health News:Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63 31Health News:BD Announces Executive Appointments of President and Chief Financial Officer 2Health News:BD Announces Executive Appointments of President and Chief Financial Officer 3Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 2Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 3Health News:BD Announces Results for Fourth Fiscal Quarter and Full Year 4